Titan Medical (TMDIF) has entered into a licensing agreement with Auris Health, a Johnson & Johnson MedTech (JNJ) company, in respect of certain intellectual property of Titan. Under the Agreement, Titan has granted Auris Health a non-exclusive license to a portion of Titan’s IP.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TMDIF:
- Titan Medical Signs License Agreement with Auris Health, Inc.
- Titan Medical Announces Appointment of New Independent Member to its Board of Directors
- Titan Medical Reports Operating and Financial Results for the Second Quarter 2023
- Titan Medical Reports Voting Results From Annual General Meeting of Shareholders